Literature DB >> 10885631

Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study.

A S Brown1, C A Schaefer, R J Wyatt, R Goetz, M D Begg, J M Gorman, E S Susser.   

Abstract

We sought to examine the relationship between maternal exposure to adult respiratory infections and schizophrenia spectrum disorder (SSD) in the Prenatal Determinants of Schizophrenia (PDS) Study, a large birth cohort investigation. Previous work suggests that second trimester exposure to respiratory infection may be a risk factor for SSD. We therefore examined whether this class of infection was associated with adult SSD. For this purpose, we capitalized on several design advantages of the PDS Study, including a comprehensive, prospective data base on physician-diagnosed infections and a continuous followup in which diagnoses of SSD were made, in the majority, by face-to-face interview. Second trimester exposure to respiratory infections was associated with a significantly increased risk of SSD, adjusting for maternal smoking, education, and race (rate ratio [RR] = 2.13 [1.05-4.35], chi2 = 4.36, df= 1,p = 0.04); no associations were shown for first trimester and third trimester exposure to these respiratory infections. These findings support-and extend-previous studies suggesting that second trimester respiratory infections are risk factors for SSD. This study therefore has implications toward uncovering the etiology of schizophrenia and developing preventive strategies.

Entities:  

Mesh:

Year:  2000        PMID: 10885631     DOI: 10.1093/oxfordjournals.schbul.a033453

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  74 in total

Review 1.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

Review 2.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

Review 3.  The role of obstetric events in schizophrenia.

Authors:  Mary Catherine Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2005-11-23       Impact factor: 9.306

Review 4.  The antecedents of schizophrenia: a review of birth cohort studies.

Authors:  Joy Welham; Matti Isohanni; Peter Jones; John McGrath
Journal:  Schizophr Bull       Date:  2008-07-24       Impact factor: 9.306

Review 5.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

Authors:  Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

6.  Stereotypical alterations in cortical patterning are associated with maternal illness-induced placental dysfunction.

Authors:  Pamela A Carpentier; Ursula Haditsch; Amy E Braun; Andrea V Cantu; Hyang Mi Moon; Robin O Price; Matthew P Anderson; Vidya Saravanapandian; Khadija Ismail; Moises Rivera; James M Weimann; Theo D Palmer
Journal:  J Neurosci       Date:  2013-10-23       Impact factor: 6.167

Review 7.  Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions.

Authors:  Cindy H Liu; Matcheri S Keshavan; Ed Tronick; Larry J Seidman
Journal:  Schizophr Bull       Date:  2015-04-22       Impact factor: 9.306

8.  Association between prenatal exposure to bacterial infection and risk of schizophrenia.

Authors:  Holger J Sørensen; Erik L Mortensen; June M Reinisch; Sarnoff A Mednick
Journal:  Schizophr Bull       Date:  2008-10-01       Impact factor: 9.306

Review 9.  Immune influence on adult neural stem cell regulation and function.

Authors:  Pamela A Carpentier; Theo D Palmer
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 10.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.